Business Context and Reporting Period
This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) reports events occurring on October 27, 2006, and November 1, 2006. The report details the entry into material definitive agreements regarding executive compensation and the approval of a new executive severance plan.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation arrangements and equity grants.
Material Changes and Agreements
- Executive Agreement Plan: On October 27, 2006, the Compensation Committee approved the "Executive Plan," replacing the prior "Severance Plan." Key modifications include:
- Removal of "failure to promptly and adequately perform duties" from the definition of "cause."
- Expansion of "good reason" to apply regardless of a change in control, specifically covering salary reductions exceeding 10% over 24 months (if not general to all management), work location changes exceeding 50 miles, or agreement breaches.
- Employment Agreement: John S. Watts, Jr., President and CEO of Commercial and Consumer Business, entered into a Form Employment Agreement on October 27, 2006, making him a participant in the new Executive Plan.
- Equity Grants: On November 1, 2006, Mr. Watts received:
- Stock Option Grant: 40,000 shares with an exercise price of $75.13 (closing market value on grant date).
- Restricted Stock Grant: 20,000 shares.
- Vesting Schedule: Both grants vest in two equal installments on November 1, 2008, and November 1, 2009.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk disclosed relates to the increased potential for severance payments under the revised "good reason" and "cause" definitions in the Executive Plan.
Investor Verification Checklist
- Verify the full text of the WellPoint, Inc. Executive Agreement Plan (Exhibit 10.7) to understand specific payment calculations.
- Confirm the vesting conditions and forfeiture provisions for the 60,000 total shares granted to John S. Watts, Jr.
- Review the impact of the revised "cause" definition on potential executive termination liabilities.
- Note that the filing date is November 2, 2006, and the company name at the time was WellPoint, Inc.